InsiderClue
Insiders · Profile

GRAY MICHAEL

CFO and COO at Upstream Bio · CFO & COO at Enliven Therapeutics · CFO at CURIS. Filing since 18 Apr 2012. CIK 0001271411

UPB Upstream Bio, Inc. CFO and COO · 3 trades ELVN Enliven Therapeutics, Inc. CFO & COO · 3 trades CRIS CURIS INC CFO · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
UPB Upstream Bio, Inc.
16 Sep 2026
CFO and COO
Sold at will
853
$4.68K
3.0%
UPB Upstream Bio, Inc.
16 Jun 2026
CFO and COO
Sold at will
853
$5.20K
2.9%
UPB Upstream Bio, Inc.
16 Mar 2026
CFO and COO
Sold at will
852
$7.92K
2.8%
ELVN Enliven Therapeutics, Inc.
22 Feb 2023
CFO & COO
Sold, plan not stated
9,856
$46.03K
26.3%
ELVN Enliven Therapeutics, Inc.
30 Jan 2023
CFO & COO
Sold, plan not stated
3,596
$14.10K
8.8%
ELVN Enliven Therapeutics, Inc.
11 Dec 2020
CFO & COO
Sold, plan not stated
1,250
$31.25K
100%
CRIS CURIS INC
12 Nov 2013
CFO
Bought
10,000
$28.60K
10.3%
CRIS CURIS INC
18 Sep 2012
COO and CFO
Sold, plan not stated
26,250
$112.35K
23.3%
CRIS CURIS INC
19 Apr 2012
COO and CFO
Sold, plan not stated
2,421
$12.13K
2.7%
CRIS CURIS INC
18 Apr 2012
COO and CFO
Sold, plan not stated
40,423
$202.52K
31.8%
10 decisions on file.